Studying Health Outcomes After Treatment in Patients With Retinoblastoma
Research Into Visual Endpoints and RB Health Outcomes After Treatment (RIVERBOAT)
Vanderbilt-Ingram Cancer Center
900 participants
Jan 24, 2019
OBSERVATIONAL
Conditions
Summary
This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Collection of tissue and saliva samples
Undergo vision assessment
Complete questionnaires
Complete questionnaires
Correlative studies
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03932786